Clik here to view.
Q2 medtech investment strong in Minnesota
Investment in Minnesota medical technology companies was strong again in the 2nd quarter, Minneapolis-based trade group LifeScience Alley said this week, with mHealth drawing particular attention....
View ArticleClik here to view.
What makes Minnesota’s ‘Medical Alley’ tick? A podcast with LifeScience...
In this episode of DeviceTalks, we catch up with LifeScience Alley CEO Shaye Mandle about doing business in Minnesota’s world class medical device cluster. We delve into why the medical device and...
View ArticleClik here to view.
Minnesota 3Q life-science investments down from 2014, but healthy pipeline...
By Scott Wooldridge Life-science companies had another good quarter in Minnesota, and although the 3Q numbers are under the record-breaking investments for 2014, a large number of investments in new...
View ArticleClik here to view.
Minnesota’s LifeScience Alley returns to roots, rebrands as Medical Alley
LifeScience Alley, the trade association serving Minnesota’s medical device, biopharmaceutical, diagnostics and digital health sector, is returning to its original moniker, Medical Alley. Formed in...
View ArticleClik here to view.
Medical device investments in Minnesota hit record level in 2015
Investment in medical device companies in Minnesota topped the $300 million mark for a 3rd year in a row last year, according to a report from the Medical Alley Assn., the North Star State’s life...
View ArticleClik here to view.
Firms in Minnesota’s Medical Alley raised $117m in Q3
Firms in Minnesota’s Medical Alley raised $117 million during the 3rd quarter, bringing their total year-to-date funding to $335.8 million, the trade group reported today. Medical Alley, which...
View ArticleClik here to view.
Biolase board of directors cut by DE judge | Medtech personnel moves for the...
UPDATE: Court cuts Biolase board, marketing VP under fire March 24, 2014 by Arezu Sarvestani Biolase continues to swat at challenges to its leadership, after a Delaware state judge cut the board of...
View ArticleClik here to view.
Medtech funding soars in Minnesota in Q2
Minnesota medical device startups got a big boost in funding in the 2nd quarter of 2014, with 134% more money invested than during the same period last year, according to a new report. The numbers...
View ArticleClik here to view.
LifeScience Alley Names Winners for 2014 New Technology Showcase
MINNEAPOLIS, MN – (September 24, 2014) – LifeScience Alley® named 10 companies to this year’s New Technology Showcase, which recognizes groundbreaking advancements in healthcare technology and provides...
View ArticleClik here to view.
Report: Minnesota life science investment closes in on 5-year high
Investment in Minnesota life science companies is on track to hit a 5-year high by the end of 2014, according to a new report from LifeScience Alley. The industry group, whose membership includes...
View ArticleClik here to view.
Astute Medical to receive up to $30M from CRG for kidney-injury test |...
FDA nod triggers $30m milestone for Astute Medical October 10, 2014 by Alexander Soule Astute Medical said it’s in line to receive up to $30 million under a standing loan agreement from funding...
View ArticleClik here to view.
Medtronic CEO Ishrak defends Covidien deal
Omar Ishrak is trying to keep his eye on the ball. At LifeScience Alley’s yearly convention in Minneapolis, the Medtronic (NYSE:MDT) chairman & CEO used a keynote Q & A interview to reinforce...
View ArticleClik here to view.
Medical device marketing in a post-Obamacare world
Medical device manufacturers are facing a shrinking number of buyers and an increasingly sophisticated healthcare world, in which Twitter and Facebook may spread word of their products more swiftly...
View ArticleMedtronic CEO Omar Ishrak on Covidien deal, value based healthcare at LSA2014
Medtronic CEO Omar Ishrak speaks with Lifescience Alley CEO Shaye Mandle at LSA2014. The post Medtronic CEO Omar Ishrak on Covidien deal, value based healthcare at LSA2014 appeared first on MassDevice.
View ArticleClik here to view.
Medtech investment hits 6-year high in Minnesota
Investment in Minnesota’s thriving medtech scene hit a 6-year high in 2014 and the state saw a significant jump in pharma/biotech investments, according to LifeScience Alley’s annual report. The...
View ArticleClik here to view.
LifeScience Alley’s new chairman is CVRx CTO Kieval
LifeScience Alley, the Minneapolis-based trade association of medical device and life science companies, has chosen a new board chair and made other changes to its board of directors. The association...
View ArticleClik here to view.
Medtech investment in Minnesota falls back to earth
After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical 1st quarter, according to a report from medtech lobby LifeScience Alley. Officials with...
View ArticleClik here to view.
Medtech investment in MN falls back to earth | Medtech funding for the week...
Medtech investment in Minnesota falls back to earth April 17, 2015 by Scott Wooldridge After an off-the-charts year in investment for 2014, the Minnesota bioscience industry has seen a more typical...
View ArticleClik here to view.
Reimbursement a top concern for medtech startups
Reimbursement issues have become 1 of the top concerns for medtech startups, a panel at a Minneapolis conference said yesterday. In the past, FDA regulations, clinical trials, or finding investors...
View ArticleClik here to view.
Medtech funding in today’s environment
Financing for medtech startups can still be found, but the market climate is less than ideal, panelists at a LifeScience Alley conference said this week in Minneapolis. The panel, "Financing...
View ArticleClik here to view.
Medtech startups outsource R&D
Starting a medtech company comes with a host of challenges, from regulation to financing to reimbursement. One way that companies can overcome those challenges, according to 2 industry experts, is to...
View ArticleClik here to view.
Medical Alley charts path for Minnesota’s medtech cluster
Medical Alley today release a 10-year strategic plan to guide the medical technology cluster in Minnesota that seeks to have the state “recognized as the global epicenter of health innovation and...
View ArticleClik here to view.
3 ways HHS can help medtech innovators
The U.S. Department of Health and Human Services (HHS) is doing everything from sharing more data to cultivating entrepreneurial talent and engaging in partnerships in order to support medical device...
View ArticleClik here to view.
Where medtech is putting its money this November
Photo by Louis Velasquez on Unsplash Republicans reaped nearly $3.3 million in federal political contributions from the medtech industry in the 2017-18 election cycle, compared with $1.85 million for...
View ArticleClik here to view.
From Frankenstein to Medical Alley: Earl Bakken remembered
Earl Bakken demonstrates a hair-raising electrical experience at The Bakken Museum in Minneapolis. Earl Bakken was eight years old when he saw the movie Frankenstein and became fascinated with the...
View Article
